Annual ROE
-139.03%
-36.66%-35.81%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual return on equity is -139.03%, with the most recent change of -36.66% (-35.81%) on December 1, 2023.
- During the last 3 years, NBY annual ROE has risen by +27.08% (+16.30%).
- NBY annual ROE is now -137.36% below its all-time high of 372.17%, reached on December 31, 2015.
Performance
NBY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-461.38%
-172.49%-59.71%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly return on equity is -461.38%, with the most recent change of -172.49% (-59.71%) on September 1, 2024.
- Over the past year, NBY quarterly ROE has dropped by -320.70% (-227.96%).
- NBY quarterly ROE is now -143.18% below its all-time high of 1068.54%, reached on March 31, 2016.
Performance
NBY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NBY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.8% | -228.0% |
| 3 y3 years | +16.3% | -338.2% |
| 5 y5 years | +19.8% | -338.2% |
NBY ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -168.4% | at low | -2308.0% | at low |
| 5 y | 5-year | -168.4% | +57.3% | -2308.0% | +36.7% |
| alltime | all time | -137.4% | +89.4% | -143.2% | +80.4% |
NovaBay Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -461.38%(+59.7%) |
| Jun 2024 | - | -288.89%(+45.4%) |
| Mar 2024 | - | -198.74%(+58.2%) |
| Dec 2023 | -139.03%(+35.8%) | -125.66%(-10.7%) |
| Sep 2023 | - | -140.68%(+33.6%) |
| Jun 2023 | - | -105.30%(+14.8%) |
| Mar 2023 | - | -91.70%(+17.6%) |
| Dec 2022 | -102.37%(+97.7%) | -78.00%(+307.1%) |
| Sep 2022 | - | -19.16%(-47.8%) |
| Jun 2022 | - | -36.69%(-1.2%) |
| Mar 2022 | - | -37.13%(-31.1%) |
| Dec 2021 | -51.79%(-68.8%) | -53.88%(-16.1%) |
| Sep 2021 | - | -64.24%(-24.0%) |
| Jun 2021 | - | -84.58%(-41.7%) |
| Mar 2021 | - | -145.11%(-26.9%) |
| Dec 2020 | -166.11%(-49.0%) | -198.49%(-38.9%) |
| Sep 2020 | - | -325.09%(-55.4%) |
| Jun 2020 | - | -728.50%(+31.1%) |
| Mar 2020 | - | -555.63%(+34.0%) |
| Dec 2019 | -325.90%(+87.9%) | -414.58%(+68.4%) |
| Sep 2019 | - | -246.21%(+10.1%) |
| Jun 2019 | - | -223.54%(+48.1%) |
| Mar 2019 | - | -150.90%(+37.9%) |
| Dec 2018 | -173.42%(+13.6%) | -109.42%(+30.7%) |
| Sep 2018 | - | -83.70%(-25.7%) |
| Jun 2018 | - | -112.66%(-15.2%) |
| Mar 2018 | - | -132.83%(-31.5%) |
| Dec 2017 | -152.72%(-88.4%) | -193.88%(-8.6%) |
| Sep 2017 | - | -212.01%(-28.0%) |
| Jun 2017 | - | -294.26%(-59.0%) |
| Mar 2017 | - | -718.58%(-44.6%) |
| Dec 2016 | -1313.13%(-452.8%) | -1297.90%(-268.3%) |
| Sep 2016 | - | 771.27%(+64.0%) |
| Jun 2016 | - | 470.40%(-56.0%) |
| Mar 2016 | - | 1068.54%(-145.4%) |
| Dec 2015 | 372.17% | -2353.97%(+262.6%) |
| Sep 2015 | - | -649.11%(+69.7%) |
| Jun 2015 | - | -382.47%(+44.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -264.60%(+29.2%) |
| Dec 2014 | -293.21%(+106.2%) | -204.72%(+12.1%) |
| Sep 2014 | - | -182.66%(+6.4%) |
| Jun 2014 | - | -171.69%(-4.6%) |
| Mar 2014 | - | -180.03%(+2.2%) |
| Dec 2013 | -142.18%(+136.7%) | -176.15%(+9.9%) |
| Sep 2013 | - | -160.31%(+38.6%) |
| Jun 2013 | - | -115.64%(+21.9%) |
| Mar 2013 | - | -94.90%(+18.4%) |
| Dec 2012 | -60.08%(+17.2%) | -80.18%(-17.5%) |
| Sep 2012 | - | -97.22%(+5.5%) |
| Jun 2012 | - | -92.18%(+58.0%) |
| Mar 2012 | - | -58.34%(+17.8%) |
| Dec 2011 | -51.28%(+41.9%) | -49.51%(+297.4%) |
| Sep 2011 | - | -12.46%(-58.8%) |
| Jun 2011 | - | -30.22%(-31.5%) |
| Mar 2011 | - | -44.10%(+17.3%) |
| Dec 2010 | -36.15%(-238.7%) | -37.58%(+302.4%) |
| Sep 2010 | - | -9.34%(-310.8%) |
| Jun 2010 | - | 4.43%(-68.0%) |
| Mar 2010 | - | 13.84%(-53.6%) |
| Dec 2009 | 26.07%(-134.8%) | 29.81%(-207.2%) |
| Sep 2009 | - | -27.81%(-37.5%) |
| Jun 2009 | - | -44.50%(-29.9%) |
| Mar 2009 | - | -63.52%(-18.4%) |
| Dec 2008 | -74.90%(+11.9%) | -77.85%(-17.6%) |
| Sep 2008 | - | -94.51%(-23.3%) |
| Jun 2008 | - | -123.23%(-19.7%) |
| Mar 2008 | - | -153.39%(-24.4%) |
| Dec 2007 | -66.94%(-67.9%) | -202.93%(-82.6%) |
| Sep 2007 | - | -1163.84%(+179.6%) |
| Jun 2007 | - | -416.24%(+4.9%) |
| Mar 2007 | - | -396.88%(+36.1%) |
| Dec 2006 | -208.73%(+96.0%) | -291.56%(+91.5%) |
| Sep 2006 | - | -152.24%(+11.4%) |
| Jun 2006 | - | -136.62%(+16.4%) |
| Mar 2006 | - | -117.34%(+10.2%) |
| Dec 2005 | -106.49%(-12.6%) | -106.52% |
| Dec 2003 | -121.82% | - |
FAQ
- What is NovaBay Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual ROE year-on-year change?
- What is NovaBay Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly ROE year-on-year change?
What is NovaBay Pharmaceuticals annual return on equity?
The current annual ROE of NBY is -139.03%
What is the all time high annual ROE for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual return on equity is 372.17%
What is NovaBay Pharmaceuticals annual ROE year-on-year change?
Over the past year, NBY annual return on equity has changed by -36.66% (-35.81%)
What is NovaBay Pharmaceuticals quarterly return on equity?
The current quarterly ROE of NBY is -461.38%
What is the all time high quarterly ROE for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly return on equity is 1068.54%
What is NovaBay Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, NBY quarterly return on equity has changed by -320.70% (-227.96%)